Correlation Between Sarofim Equity and Jpmorgan Growth

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sarofim Equity and Jpmorgan Growth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarofim Equity and Jpmorgan Growth into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sarofim Equity and Jpmorgan Growth Advantage, you can compare the effects of market volatilities on Sarofim Equity and Jpmorgan Growth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarofim Equity with a short position of Jpmorgan Growth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarofim Equity and Jpmorgan Growth.

Diversification Opportunities for Sarofim Equity and Jpmorgan Growth

0.9
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Sarofim and Jpmorgan is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Sarofim Equity and Jpmorgan Growth Advantage in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jpmorgan Growth Advantage and Sarofim Equity is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarofim Equity are associated (or correlated) with Jpmorgan Growth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jpmorgan Growth Advantage has no effect on the direction of Sarofim Equity i.e., Sarofim Equity and Jpmorgan Growth go up and down completely randomly.

Pair Corralation between Sarofim Equity and Jpmorgan Growth

Assuming the 90 days horizon Sarofim Equity is expected to generate 2.84 times less return on investment than Jpmorgan Growth. But when comparing it to its historical volatility, Sarofim Equity is 1.23 times less risky than Jpmorgan Growth. It trades about 0.05 of its potential returns per unit of risk. Jpmorgan Growth Advantage is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  3,073  in Jpmorgan Growth Advantage on September 12, 2024 and sell it today you would earn a total of  1,513  from holding Jpmorgan Growth Advantage or generate 49.24% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Sarofim Equity  vs.  Jpmorgan Growth Advantage

 Performance 
       Timeline  
Sarofim Equity 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sarofim Equity are ranked lower than 7 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong primary indicators, Sarofim Equity is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Jpmorgan Growth Advantage 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Jpmorgan Growth Advantage are ranked lower than 15 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Jpmorgan Growth may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Sarofim Equity and Jpmorgan Growth Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sarofim Equity and Jpmorgan Growth

The main advantage of trading using opposite Sarofim Equity and Jpmorgan Growth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarofim Equity position performs unexpectedly, Jpmorgan Growth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jpmorgan Growth will offset losses from the drop in Jpmorgan Growth's long position.
The idea behind Sarofim Equity and Jpmorgan Growth Advantage pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device